The polyphenol compound curcumin, derived from the spice turmeric (Curcuma longa), has been demonstrated to inhibit the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signalling pathway in a range of cancer types, including rhabdomyosarcoma. This evidence concerns the gene NFKB1 and cancer.